The urgency of the COVID-19 pandemic allowed vaccine makers to accelerate the normally slow pace of vaccine development and manufacturing. "But as a third pandemic winter begins in the United
States, its vaccine-making effort has lost steam," per The New York Times. "Efforts to test and produce next-generation Covid vaccines are bogged down by bureaucratic problems and funding
shortfalls. Foreign rivals have raced ahead in approving
long-awaited nasal-spray vaccines, including one invented in St. Louis, creating a scenario in which Americans would have to
travel abroad for the latest in American vaccine technology."
Read the whole story at The New York Times »